These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 29530495)
1. Geriatric assessment-driven polypharmacy discussions between oncologists, older patients, and their caregivers. Ramsdale E; Lemelman T; Loh KP; Flannery M; Kehoe L; Mullaney T; Wells M; Gilmore N; Plumb S; Mohile S J Geriatr Oncol; 2018 Sep; 9(5):534-539. PubMed ID: 29530495 [TBL] [Abstract][Full Text] [Related]
2. Communication With Older Patients With Cancer Using Geriatric Assessment: A Cluster-Randomized Clinical Trial From the National Cancer Institute Community Oncology Research Program. Mohile SG; Epstein RM; Hurria A; Heckler CE; Canin B; Culakova E; Duberstein P; Gilmore N; Xu H; Plumb S; Wells M; Lowenstein LM; Flannery MA; Janelsins M; Magnuson A; Loh KP; Kleckner AS; Mustian KM; Hopkins JO; Liu JJ; Geer J; Gorawara-Bhat R; Morrow GR; Dale W JAMA Oncol; 2020 Feb; 6(2):196-204. PubMed ID: 31697365 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer. Nightingale G; Hajjar E; Swartz K; Andrel-Sendecki J; Chapman A J Clin Oncol; 2015 May; 33(13):1453-9. PubMed ID: 25800766 [TBL] [Abstract][Full Text] [Related]
4. Associations of Polypharmacy and Inappropriate Medications with Adverse Outcomes in Older Adults with Cancer: A Systematic Review and Meta-Analysis. Mohamed MR; Ramsdale E; Loh KP; Arastu A; Xu H; Obrecht S; Castillo D; Sharma M; Holmes HM; Nightingale G; Juba KM; Mohile SG Oncologist; 2020 Jan; 25(1):e94-e108. PubMed ID: 31570516 [TBL] [Abstract][Full Text] [Related]
5. Evaluating the association of frailty with communication about aging-related concerns between older patients with advanced cancer and their oncologists. Gilmore N; Xu H; Kehoe L; Kleckner AS; Moorthi K; Lei L; Mohamed MRS; Loh KP; Culakova E; Flannery M; Ramsdale E; Duberstein PR; Canin B; Kamen C; Giri G; Watson E; Patil A; Onitilo AA; Burnette B; Janelsins M; Mohile SG Cancer; 2022 Mar; 128(5):1101-1109. PubMed ID: 34762734 [TBL] [Abstract][Full Text] [Related]
6. Impact of Computer-Based and Pharmacist-Assisted Medication Review Initiated in the Emergency Department. Liu YL; Chu LL; Su HC; Tsai KT; Kao PH; Chen JF; Hsieh HC; Lin HJ; Hsu CC; Huang CC J Am Geriatr Soc; 2019 Nov; 67(11):2298-2304. PubMed ID: 31335969 [TBL] [Abstract][Full Text] [Related]
7. Polypharmacy and potentially inappropriate medication use in geriatric oncology. Sharma M; Loh KP; Nightingale G; Mohile SG; Holmes HM J Geriatr Oncol; 2016 Sep; 7(5):346-53. PubMed ID: 27498305 [TBL] [Abstract][Full Text] [Related]
8. Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First-Line Palliative Chemotherapy. Hong S; Lee JH; Chun EK; Kim KI; Kim JW; Kim SH; Lee YG; Hwang IG; Kim JY; Koh SJ; Ko YH; Shin SH; Woo IS; Kim TY; Baek JY; Kim HJ; Kim HJ; Lee MA; Kwon JH; Hong YS; Ryoo HM; Kim JH Oncologist; 2020 Mar; 25(3):e502-e511. PubMed ID: 32162799 [TBL] [Abstract][Full Text] [Related]
9. Polypharmacy, potentially inappropriate medications and drug-drug interactions in geriatric patients with hematologic malignancy: Observational single-center study of 122 patients. Leger DY; Moreau S; Signol N; Fargeas JB; Picat MA; Penot A; Abraham J; Laroche ML; Bordessoule D J Geriatr Oncol; 2018 Jan; 9(1):60-67. PubMed ID: 28851511 [TBL] [Abstract][Full Text] [Related]
10. Using Geriatric Assessment to Guide Conversations Regarding Comorbidities Among Older Patients With Advanced Cancer. Kleckner AS; Wells M; Kehoe LA; Gilmore NJ; Xu H; Magnuson A; Dunne RF; Jensen-Battaglia M; Mohamed MR; O'Rourke MA; Vogelzang NJ; Dib EG; Peppone LJ; Mohile SG JCO Oncol Pract; 2022 Jan; 18(1):e9-e19. PubMed ID: 34228510 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive pharmacological geriatric assessment compared to usual care in an older adult with cancer in the absence of polypharmacy. Walsh DJ; Sahm LJ; O'Driscoll M; Tabb E; Hannan M; Horgan AM J Oncol Pharm Pract; 2023 Oct; 29(7):1776-1780. PubMed ID: 37332111 [TBL] [Abstract][Full Text] [Related]
12. Association of Oncologist-Patient Communication With Functional Status and Physical Performance in Older Adults: A Secondary Analysis of a Cluster Randomized Clinical Trial. Jensen-Battaglia M; Lei L; Xu H; Kehoe L; Patil A; Loh KP; Ramsdale E; Magnuson A; Kleckner AS; Wildes TM; Lin PJ; Mustian KM; Giri G; Whitehead M; Bearden J; Burnette BL; Geer J; Mohile SG; Dunne RF JAMA Netw Open; 2022 Mar; 5(3):e223039. PubMed ID: 35302628 [TBL] [Abstract][Full Text] [Related]
13. Effect of Clinical Geriatric Assessments and Collaborative Medication Reviews by Geriatrician and Family Physician for Improving Health-Related Quality of Life in Home-Dwelling Older Patients Receiving Polypharmacy: A Cluster Randomized Clinical Trial. Romskaug R; Skovlund E; Straand J; Molden E; Kersten H; Pitkala KH; Lundqvist C; Wyller TB JAMA Intern Med; 2020 Feb; 180(2):181-189. PubMed ID: 31617562 [TBL] [Abstract][Full Text] [Related]
14. Family conferences and shared prioritisation to improve patient safety in the frail elderly (COFRAIL): study protocol of a cluster randomised intervention trial in primary care. Mortsiefer A; Wilm S; Santos S; Löscher S; Wollny A; Drewelow E; Ritzke M; Thürmann P; Mann NK; Meyer G; Abraham J; Icks A; Montalbo J; Wiese B; Altiner A; Trials; 2020 Mar; 21(1):285. PubMed ID: 32197631 [TBL] [Abstract][Full Text] [Related]
15. Medication review versus usual care to improve drug therapies in older inpatients not admitted to geriatric wards: a quasi-experimental study (RASP-IGCT). Van der Linden L; Hias J; Dreessen L; Milisen K; Flamaing J; Spriet I; Tournoy J BMC Geriatr; 2018 Jul; 18(1):155. PubMed ID: 29970005 [TBL] [Abstract][Full Text] [Related]
16. Combined Use of the Rationalization of Home Medication by an Adjusted STOPP in Older Patients (RASP) List and a Pharmacist-Led Medication Review in Very Old Inpatients: Impact on Quality of Prescribing and Clinical Outcome. Van der Linden L; Decoutere L; Walgraeve K; Milisen K; Flamaing J; Spriet I; Tournoy J Drugs Aging; 2017 Feb; 34(2):123-133. PubMed ID: 27915457 [TBL] [Abstract][Full Text] [Related]
17. Is my older cancer patient on too many medications? Turner JP; Shakib S; Bell JS J Geriatr Oncol; 2017 Mar; 8(2):77-81. PubMed ID: 27840102 [TBL] [Abstract][Full Text] [Related]
18. A pharmacist-led medication assessment used to determine a more precise estimation of the prevalence of complementary and alternative medication (CAM) use among ambulatory senior adults with cancer. Nightingale G; Hajjar E; Guo K; Komura S; Urnoski E; Sendecki J; Swartz K; Chapman A J Geriatr Oncol; 2015 Sep; 6(5):411-7. PubMed ID: 26277113 [TBL] [Abstract][Full Text] [Related]
19. Communication About Fall Risk in Community Oncology Practice: The Role of Geriatric Assessment. Jensen-Battaglia M; Lei L; Xu H; Loh KP; Wells M; Tylock R; Ramsdale E; Kleckner AS; Mustian KM; Dunne RF; Kehoe L; Bearden J; Burnette BL; Whitehead M; Mohile SG; Wildes TM JCO Oncol Pract; 2022 Oct; 18(10):e1630-e1640. PubMed ID: 35984998 [TBL] [Abstract][Full Text] [Related]
20. Identifying potentially inappropriate medication (PIM) use in geriatric oncology. Miller MG; Kneuss TG; Patel JN; Parala-Metz AG; Haggstrom DE J Geriatr Oncol; 2021 Jan; 12(1):34-40. PubMed ID: 32571665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]